148 related articles for article (PubMed ID: 24210736)
1. Risk reducing mastectomy, breast reconstruction and patient satisfaction in Norwegian BRCA1/2 mutation carriers.
Hagen AI; Mæhle L; Vedå N; Vetti HH; Stormorken A; Ludvigsen T; Guntvedt B; Isern AE; Schlichting E; Kleppe G; Bofin A; Gullestad HP; Møller P
Breast; 2014 Feb; 23(1):38-43. PubMed ID: 24210736
[TBL] [Abstract][Full Text] [Related]
2. Superior gluteal artery perforator flap in bilateral breast reconstruction.
Werdin F; Peek A; Martin NC; Baumeister S
Ann Plast Surg; 2010 Jan; 64(1):17-21. PubMed ID: 20010408
[TBL] [Abstract][Full Text] [Related]
3. Timing of prophylactic hysterectomy-oophorectomy, mastectomy, and microsurgical breast reconstruction in BRCA1 and BRCA2 carriers.
Khansa I; Wang D; Coriddi M; Tiwari P
Microsurgery; 2014 May; 34(4):271-6. PubMed ID: 24123194
[TBL] [Abstract][Full Text] [Related]
4. Analysis of complications and patient satisfaction in pedicled transverse rectus abdominis myocutaneous and deep inferior epigastric perforator flap breast reconstruction.
Momoh AO; Colakoglu S; Westvik TS; Curtis MS; Yueh JH; de Blacam C; Tobias AM; Lee BT
Ann Plast Surg; 2012 Jul; 69(1):19-23. PubMed ID: 21659842
[TBL] [Abstract][Full Text] [Related]
5. Satisfaction with prophylactic mastectomy and breast reconstruction in genetically predisposed women.
Bresser PJ; Seynaeve C; Van Gool AR; Brekelmans CT; Meijers-Heijboer H; van Geel AN; Menke-Pluijmers MB; Duivenvoorden HJ; Klijn JG; Tibben A
Plast Reconstr Surg; 2006 May; 117(6):1675-82; discussion 1683-4. PubMed ID: 16651934
[TBL] [Abstract][Full Text] [Related]
6. The frequency and outcome of breast cancer risk-reducing surgery in Finnish BRCA1 and BRCA2 mutation carriers.
Koskenvuo L; Svarvar C; Suominen S; Aittomäki K; Jahkola T
Scand J Surg; 2014 Mar; 103(1):34-40. PubMed ID: 24177987
[TBL] [Abstract][Full Text] [Related]
7. Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 mutation carriers.
Friebel TM; Domchek SM; Neuhausen SL; Wagner T; Evans DG; Isaacs C; Garber JE; Daly MB; Eeles R; Matloff E; Tomlinson G; Lynch HT; Tung N; Blum JL; Weitzel J; Rubinstein WS; Ganz PA; Couch F; Rebbeck TR
Clin Breast Cancer; 2007 Dec; 7(11):875-82. PubMed ID: 18269778
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic mastectomy in BRCA1/2 mutation carriers and women at risk of hereditary breast cancer: long-term experiences at the Rotterdam Family Cancer Clinic.
Heemskerk-Gerritsen BA; Brekelmans CT; Menke-Pluymers MB; van Geel AN; Tilanus-Linthorst MM; Bartels CC; Tan M; Meijers-Heijboer HE; Klijn JG; Seynaeve C
Ann Surg Oncol; 2007 Dec; 14(12):3335-44. PubMed ID: 17541692
[TBL] [Abstract][Full Text] [Related]
9. Risk-reducing mastectomy in BRCA1/2 mutation carriers: factors influencing uptake and timing.
van Driel CM; Eltahir Y; de Vries J; Jaspers JP; Oosterwijk JC; Mourits MJ; de Bock GH
Maturitas; 2014 Feb; 77(2):180-4. PubMed ID: 24268650
[TBL] [Abstract][Full Text] [Related]
10. Less correspondence between expectations before and cosmetic results after risk-reducing mastectomy in women who are mutation carriers: a prospective study.
Brandberg Y; Arver B; Johansson H; Wickman M; Sandelin K; Liljegren A
Eur J Surg Oncol; 2012 Jan; 38(1):38-43. PubMed ID: 22032910
[TBL] [Abstract][Full Text] [Related]
11. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
Rebbeck TR; Friebel T; Lynch HT; Neuhausen SL; van 't Veer L; Garber JE; Evans GR; Narod SA; Isaacs C; Matloff E; Daly MB; Olopade OI; Weber BL
J Clin Oncol; 2004 Mar; 22(6):1055-62. PubMed ID: 14981104
[TBL] [Abstract][Full Text] [Related]
12. Aesthetic outcome, patient satisfaction, and health-related quality of life in women at high risk undergoing prophylactic mastectomy and immediate breast reconstruction.
Isern AE; Tengrup I; Loman N; Olsson H; Ringberg A
J Plast Reconstr Aesthet Surg; 2008 Oct; 61(10):1177-87. PubMed ID: 17938010
[TBL] [Abstract][Full Text] [Related]
13. Contralateral risk-reducing mastectomy in BRCA1 and BRCA2 mutation carriers and other high-risk women in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab).
Kiely BE; Jenkins MA; McKinley JM; Friedlander ML; Weideman P; Milne RL; McLachlan SA; Hopper JL; Phillips KA
Breast Cancer Res Treat; 2010 Apr; 120(3):715-23. PubMed ID: 19669874
[TBL] [Abstract][Full Text] [Related]
14. Rates of risk-reducing surgery in Israeli BRCA1 and BRCA2 mutation carriers.
Laitman Y; Vaisman Y; Feldman D; Helpman L; Gitly M; Paluch Shimon S; Berger R; Cohen L; Narod SA; Friedman E
Clin Genet; 2014 Jan; 85(1):68-71. PubMed ID: 23517234
[TBL] [Abstract][Full Text] [Related]
15. Breast Cancer Incidence After Risk-Reducing Salpingo-Oophorectomy in BRCA1 and BRCA2 Mutation Carriers.
Fakkert IE; Mourits MJ; Jansen L; van der Kolk DM; Meijer K; Oosterwijk JC; van der Vegt B; Greuter MJ; de Bock GH
Cancer Prev Res (Phila); 2012 Nov; 5(11):1291-7. PubMed ID: 23009828
[TBL] [Abstract][Full Text] [Related]
16. Nipple-sparing mastectomy in BRCA1/2 mutation carriers: an interim analysis and review of the literature.
Yao K; Liederbach E; Tang R; Lei L; Czechura T; Sisco M; Howard M; Hulick PJ; Weissman S; Winchester DJ; Coopey SB; Smith BL
Ann Surg Oncol; 2015 Feb; 22(2):370-6. PubMed ID: 25023546
[TBL] [Abstract][Full Text] [Related]
17. [Surgical prevention of breast carcinoma in patients with hereditary risk].
Dražan L; Veselý J; Hýža P; Kubek T; Foretová L; Coufal O
Klin Onkol; 2012; 25 Suppl():S78-83. PubMed ID: 22920212
[TBL] [Abstract][Full Text] [Related]
18. Risk-reducing surgery, screening and chemoprevention practices of BRCA1 and BRCA2 mutation carriers: a prospective cohort study.
Phillips KA; Jenkins MA; Lindeman GJ; McLachlan SA; McKinley JM; Weideman PC; Hopper JL; Friedlander ML;
Clin Genet; 2006 Sep; 70(3):198-206. PubMed ID: 16922722
[TBL] [Abstract][Full Text] [Related]
19. Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation.
Meijers-Heijboer H; Brekelmans CT; Menke-Pluymers M; Seynaeve C; Baalbergen A; Burger C; Crepin E; van den Ouweland AW; van Geel B; Klijn JG
J Clin Oncol; 2003 May; 21(9):1675-81. PubMed ID: 12721241
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic mastectomy in BRCA1 and BRCA2 mutation carriers: very low risk for subsequent breast cancer.
Kaas R; Verhoef S; Wesseling J; Rookus MA; Oldenburg HS; Peeters MJ; Rutgers EJ
Ann Surg; 2010 Mar; 251(3):488-92. PubMed ID: 20134318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
